fbpx

ZEN LOSS ALERT: ROSEN LAW FIRM Reminds Zendesk, Inc. Investors of Important December 23rd Deadline in Securities Class Action – ZEN

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zendesk, Inc. (NYSE: ZEN) between February 6,

Read more

bluebird bio Presents New Data from Ongoing Phase 1/2 HGB-206 Study of LentiGlobin™ Gene Therapy for Sickle Cell Disease (SCD) at 61st ASH Annual Meeting and Exposition

99% reduction in annualized rate of vaso-occlusive crises (VOC) and acute chest syndrome (ACS) in Group C patients with history of VOCs and ACS

Read more

Seattle Genetics Announces Updated Data of ADCETRIS® (Brentuximab Vedotin) in Combination with OPDIVO® (Nivolumab) in Frontline and Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting

– Additional Analysis in Phase 2 Trial of ADCETRIS plus OPDIVO in Patients with Frontline Hodgkin Lymphoma Aged 60 Years and Older – –

Read more

Nihon Kohden Donates to Epilepsy Research for 11th Consecutive Year

Company’s Annual Contributions to American Epilepsy Society Have Totaled More Than $275,000 IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products

Read more